157 related articles for article (PubMed ID: 15713424)
1. FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action.
Price RD; Yamaji T; Yamamoto H; Higashi Y; Hanaoka K; Yamazaki S; Ishiye M; Aramori I; Matsuoka N; Mutoh S; Yanagihara T; Gold BG
Eur J Pharmacol; 2005 Feb; 509(1):11-9. PubMed ID: 15713424
[TBL] [Abstract][Full Text] [Related]
2. The Neurotrophic Effects and Mechanism of Action for FK1706 in Neurorrhaphy Rat Models and SH-SY5Y Cells.
Gao W; Yang H; Xu L; Huang W; Yang Y
Neurochem Res; 2021 Nov; 46(11):2897-2908. PubMed ID: 34228232
[TBL] [Abstract][Full Text] [Related]
3. FK1706, a novel non-immunosuppressive immunophilin ligand, modifies gene expression in the dorsal root ganglia during painful diabetic neuropathy.
Yamazaki S; Yamaji T; Murai N; Yamamoto H; Matsuda T; Price RD; Matsuoka N
Neurol Res; 2012 Jun; 34(5):469-77. PubMed ID: 22642793
[TBL] [Abstract][Full Text] [Related]
4. FK1706, a novel non-immunosuppressive immunophilin ligand, modifies the course of painful diabetic neuropathy.
Yamazaki S; Yamaji T; Murai N; Yamamoto H; Price RD; Matsuoka N; Mutoh S
Neuropharmacology; 2008 Dec; 55(7):1226-30. PubMed ID: 18760290
[TBL] [Abstract][Full Text] [Related]
5. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506.
Gold BG; Densmore V; Shou W; Matzuk MM; Gordon HS
J Pharmacol Exp Ther; 1999 Jun; 289(3):1202-10. PubMed ID: 10336507
[TBL] [Abstract][Full Text] [Related]
6. FK506 and the role of immunophilins in nerve regeneration.
Gold BG
Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
[TBL] [Abstract][Full Text] [Related]
7. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
8. FK506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway.
Price RD; Yamaji T; Matsuoka N
Br J Pharmacol; 2003 Nov; 140(5):825-9. PubMed ID: 14559856
[TBL] [Abstract][Full Text] [Related]
9. The role of immunophilin ligands in nerve regeneration.
Toll EC; Seifalian AM; Birchall MA
Regen Med; 2011 Sep; 6(5):635-52. PubMed ID: 21916598
[TBL] [Abstract][Full Text] [Related]
10. A role for schwann cells in the neuroregenerative effects of a non-immunosuppressive fk506 derivative, jnj460.
Birge RB; Wadsworth S; Akakura R; Abeysinghe H; Kanojia R; MacIelag M; Desbarats J; Escalante M; Singh K; Sundarababu S; Parris K; Childs G; August A; Siekierka J; Weinstein DE
Neuroscience; 2004; 124(2):351-66. PubMed ID: 14980385
[TBL] [Abstract][Full Text] [Related]
11. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation.
Matsuda S; Shibasaki F; Takehana K; Mori H; Nishida E; Koyasu S
EMBO Rep; 2000 Nov; 1(5):428-34. PubMed ID: 11258483
[TBL] [Abstract][Full Text] [Related]
12. Regulation of MAPK signaling pathways through immunophilin-ligand complex.
Matsuda S; Koyasu S
Curr Top Med Chem; 2003; 3(12):1358-67. PubMed ID: 12871167
[TBL] [Abstract][Full Text] [Related]
13. Role of immunophilins in recovery of erectile function after cavernous nerve injury.
Sezen SF; Lagoda G; Burnett AL
J Sex Med; 2009 Mar; 6 Suppl 3(Suppl 3):340-6. PubMed ID: 19267858
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent inhibitory effects of (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4-azatricyclo[22.3.1.0(4.9)]octacos-18-ene-2,3,10,16-tetrone (FK1706), a novel nonimmunosuppressive immunophilin ligand, on CYP3A4/5 activity in humans in vivo and in vitro.
Minematsu T; Lee J; Zha J; Moy S; Kowalski D; Hori K; Ishibashi K; Usui T; Kamimura H
Drug Metab Dispos; 2010 Feb; 38(2):249-59. PubMed ID: 19889885
[TBL] [Abstract][Full Text] [Related]
15. FK1706, a novel non-immunosuppressant neurophilin ligand, ameliorates motor dysfunction following spinal cord injury through its neuroregenerative action.
Yamaji T; Yamazaki S; Li J; Price RD; Matsuoka N; Mutoh S
Eur J Pharmacol; 2008 Sep; 591(1-3):147-52. PubMed ID: 18602914
[TBL] [Abstract][Full Text] [Related]
16. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.
Guo X; Dawson VL; Dawson TM
Eur J Neurosci; 2001 May; 13(9):1683-93. PubMed ID: 11359520
[TBL] [Abstract][Full Text] [Related]
17. FK506 and rapamycin neuroprotect erection and involve different immunophilins in a rat model of cavernous nerve injury.
Lagoda G; Sezen SF; Burnett AL
J Sex Med; 2009 Jul; 6(7):1914-23. PubMed ID: 19453873
[TBL] [Abstract][Full Text] [Related]
18. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration.
Gold BG
Drug Metab Rev; 1999 Aug; 31(3):649-63. PubMed ID: 10461545
[TBL] [Abstract][Full Text] [Related]
19. Proof that the high molecular weight immunophilin FKBP52 mediates the in vivo neuroregenerative effect of the macrolide FK506.
Daneri-Becerra C; Patiño-Gaillez MG; Galigniana MD
Biochem Pharmacol; 2020 Dec; 182():114204. PubMed ID: 32828804
[TBL] [Abstract][Full Text] [Related]
20. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
Davies TH; Ning YM; Sánchez ER
Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
